DNase hypersensitivity drug
Evidence from:
primary |
all sources
Related entities (2)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| DNase hypersensitivity | interacts_with | enhancer | — | 1 |
| Roadmap Epigenomics consortium | associated_with | DNase hypersensitivity | — | 1 |
Mentioned in (7)
Papers in which this entity is mentioned.
- A statistical framework for multi-trait rare variant analysis in large-scale whole-genome sequencing studies. (2025)
- Genetic architecture of 11 major psychiatric disorders at biobehavioral, functional genomic and molecular genetic levels of analysis. (2022)
- Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types. (2018)
- Positively selected enhancer elements endow osteosarcoma cells with metastatic competence. (2018)
- The landscape of long noncoding RNAs in the human transcriptome. (2015)
- Reconstructing A/B compartments as revealed by Hi-C using long-range correlations in epigenetic data. (2015)
- An atlas of active enhancers across human cell types and tissues. (2014)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| dnase hypersensitivity | drug | 7 | 9 |
| dnase i hypersensitivity | drug | 2 | 2 |